Refresh

Tatva Chintan Pharma Chem Ltd. - Research Center

543321 TATVA Group (B) BSE data
Back to Company

Results

Statement

More

Profit & Loss Account
(Rs crore)
Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20
Income

Operating income

403.04 427.81 291.19 253.84
Expenses

Material consumed

239.15 209.49 151.79 135.80

Manufacturing expenses

23.61 22.62 9.92 8.96

Personnel expenses

38.60 30.81 24.13 20.53

Selling expenses

- - - -

Adminstrative expenses

47.01 59.12 40.16 36.16

Expenses capitalised

- - - -

Cost of sales

348.37 322.04 226.00 201.45

Operating profit

54.68 105.77 65.19 52.39

Other recurring income

5.68 10.51 5.10 0.56

Adjusted PBDIT

60.36 116.28 70.29 52.95

Financial expenses

8.38 4.83 4.21 3.94

Depreciation

9.55 8.18 6.73 4.79

Other write offs

- - - -

Adjusted PBT

42.42 103.27 59.35 44.22

Tax charges

-1.63 7.28 7.99 9.25

Adjusted PAT

44.05 95.99 51.36 34.96

Non recurring items

-3.59 - - -

Other non cash adjustments

- - - -

Reported net profit

40.47 95.99 51.36 34.96

Earnigs before appropriation

278.34 237.88 157.97 106.61

Equity dividend

4.43 - 4.02 -

Preference dividend

- - - -

Dividend tax

- - - -

Retained earnings

273.91 237.88 153.95 106.61
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com